In the latest close session, Ginkgo Bioworks Holdings, Inc. (DNA) was down 5.92% at $8.27. This move lagged the S&P 500's daily loss of 0.51%. Elsewhere, the Dow saw an upswing of 0.53%, while the ...

Ginkgo's share price remains under pressure, despite the business stabilizing in Q2. Ginkgo's shift away from downstream value sharing has undermined the company's bull case, which could be hard for ...

Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry Model API ...

BOSTON, Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of key assets of Reverie Labs ...

Ginkgo Bioworks' market cap has plummeted from more than $25 billion at its peak to less than $600 million at recent prices. The company has announced heaps of layoffs this year in response to heavy ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.31 in the latest trading session, marking a -1.27% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.13%.

Ginkgo Bioworks (NYSE: DNA) stock has had a rough 12 months, falling 88%, and undergoing a reverse stock split on Aug. 20 that left its shares down by around 18% in the aftermath. Depending on which ...

Which of Ginkgo's bad news was worse? I suspect the Ark Invest sales of Ginkgo stock worried investors more than the company's staffing cuts. Ginkgo announced in its first-quarter update on May 9 that ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.02 in the latest trading session, marking a -6.36% move from the prior day. This change lagged the S&P 500's 0.03% gain on the day. Elsewhere, the ...

Jason Kelly, CEO of Ginkgo Bioworks: "I'm excited to see how the community builds on top of these models and our API. AA-0 is the first model we have released trained on Ginkgo's proprietary data – we ...